Dietary pyruvate targets cytosolic phospholipase A2 to mitigate inflammation and obesity in mice

Abstract

Obesity has a multifactorial etiology and is known to be a state of chronic low-grade inflammation, known as meta-inflammation. This state is associated with the development of metabolic disorders such as glucose intolerance and nonalcoholic fatty liver disease. Pyruvate is a glycolytic metabolite and a crucial node in various metabolic pathways. However, its role and molecular mechanism in obesity and associated complications are obscure. In this study, we reported that pyruvate substantially inhibited adipogenic differentiation in vitro and its administration significantly prevented HFD-induced weight gain, white adipose tissue inflammation, and metabolic dysregulation. To identify the target proteins of pyruvate, drug affinity responsive target stability was employed with proteomics, cellular thermal shift assay, and isothermal drug response to detect the interactions between pyruvate and its molecular targets. Consequently, we identified cytosolic phospholipase A2 (cPLA2) as a novel molecular target of pyruvate and demonstrated that pyruvate restrained diet-induced obesity, white adipose tissue inflammation, and hepatic steatosis in a cPLA2-dependent manner. Studies with global ablation of cPLA2 in mice showed that the protective effects of pyruvate were largely abrogated, confirming the importance of pyruvate/cPLA2 interaction in pyruvate attenuation of inflammation and obesity. Overall, our study not only establishes pyruvate as an antagonist of cPLA2 signaling and a potential therapeutic option for obesity but it also sheds light on the mechanism of its action. Pyruvate’s prior clinical use indicates that it can be considered a safe and viable alternative for obesity, whether consumed as a dietary supplement or as part of a regular diet.

Key words： metabolic disease; pyruvate; cytosolic phospholipase; obesity

References

1 AbbottMj, TangT, SulHS. The role of phospholipase A(2)- derived mediators in obesity. Drug Discov Today Dis Mech 2010;7:e213–e218.

2 AvtanskiD, PavlovVA, TraceyKJ et al. Characterization of inflammation and insulin resistance in high-fat diet-induced male C57BL/6J mouse model of obesity. Animal Model Exp Med 2019;2:252–258.

3 BakerRG, HaydenMS, GhoshS. NF-κB, inflammation, and metabolic disease. Cell Metab 2011;13:11–22.

4 CancelloR, Henegar C, ViguerieN et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005;54:2277–2286.

5 CarlsenH, HaugenF, ZadelaarS et al. Diet-induced obesity increases NF-kappaB signaling in reporter mice. Genes Nutr 2009;4:215–222.

6 CatrysseL, Van Loo G. Inflammation and the metabolic syndrome: the tissue-specific functions of NF-κB. Trends Cell Biol 2017;27:417–429.

7 ChangI, ChoN, KohJY et al. Pyruvate inhibits zinc-mediated pancreatic islet cell death and diabetes. Diabetologia 2003;46:1220–1227.

8 ChoeSS, HuhJY, HwangIJ et al. Adipose tissue remodeling: its role in energy metabolism and metabolic disorders. Front Endocrinol (Lausanne) 2016;7:30.

9 CoulisG, JaimeD, Guerrero-JuarezC et al. Single-cell and spatial transcriptomics identify a macrophage population associated with skeletal muscle fibrosis. Sci Adv 2023;9:eadd9984.

10 DasUN. Pyruvate is an endogenous anti-inflammatory and anti-oxidant molecule. Med Sci Monit 2006;12: RA79–RA84.

11 DesprésJP, Lemieux I, BergeronJ et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008;28:1039–1049.

12 GabrielyI, Barzilai N. Surgical removal of visceral adipose tissue: effects on insulin action. Curr Diab Rep 2003;3:201–206.

13 Godoy-MatosAF, Silva Júnior WS, ValerioCM. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetol Metab Syndr 2020;12:60.

14 González-MuniesaP, Garcia-GeriqueL, Quintero P et al. Effects of hyperoxia on oxygen-related inflammation with a focus on obesity. Oxid Med Cell Longev 2015;2015:8957827.

15 GouW, WeiH, SwabyL et al. Deletion of spinophilin promotes white adipocyte browning. Pharmaceuticals (Basel) 2023;16:91.

16 HasanST, ZinggJM, KwanP et al. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice. Atherosclerosis 2014;232:40–51.

17 HeM-Q, WangJ-Y, WangY et al. High-fat diet-induced adipose tissue expansion occurs prior to insulin resistance in C57BL/6J mice. Chronic Dis Transl Med 2020;6:198–207.

18 HelsleyRN, SuiY, ParkSH et al. Targeting IκB kinase β in adipocyte lineage cells for treatment of obesity and metabolic dysfunctions. Stem Cells 2016;34:1883–1895.

19 HeoY, KimH, LimJ et al. Adipocyte differentiation between obese and lean conditions depends on changes in miRNA expression. Sci Rep 2022;12:11543.

20 HirabayashiT, Murayama T, ShimizuT. Regulatory mechanism and physiological role of cytosolic phospholipase A₂. Biol Pharm Bull 2004;27:1168–1173.

21 HotamisligilGS. Foundations of immunometabolism and implications for metabolic health and disease. Immunity 2017;47:406–420.

22 HouJ, JiangS, ZhaoJ et al. N-Myc-interacting protein negatively regulates TNF-α-induced NF-κB transcriptional activity by sequestering NF-κB/p65 in the cytoplasm. Sci Rep 2017;7:14579.

23 LiH, Yokoyama N, YoshidaS et al. Alleviation of high-fat diet-induced fatty liver damage in group IVA phospholipase A2-knockout mice. PLoS One 2009;4:e8089.

24 JangJW, LimDW, ChangJU et al. The combination of Ephedrae herba and Coicis semen in gambihwan attenuates obesity and metabolic syndrome in high-fat diet- induced obese mice. Evid Based Complement Alternat Med 2018;2018:5614091.

25 JefferyE, WingA, HoltrupB et al. The adipose tissue microenvironment regulates depot-specific adipogenesis in obesity. Cell Metab 2016;24:142–150.

26 KalmanD, ColkerCM, WiletsI et al. The effects of pyruvate supplementation on body composition in overweight individuals. Nutrition 1999;15:337–340.

27 KawaiT, Autieri MV, ScaliaR. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol 2021;320:C375–C391.

28 KolakM, Westerbacka J, VelagapudiVR et al. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 2007;56:1960–1968.

29 LeeD-K, KimT, ByeonJ et al. REDD1 promotes obesity-induced metabolic dysfunction via atypical NF-κB activation. Nat Commun 2022;13:6303.

30 LiP, LuM, NguyenMTA et al. Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice. J Biol Chem 2010;285:15333–15345.

31 LiY, RongY, BaoL et al. Suppression of adipocyte differentiation and lipid accumulation by stearidonic acid (SDA) in 3T3-L1 cells. Lipids Health Dis 2017;16:181.

32 LiC, XuMM, WangK et al. Macrophage polarization and meta-inflammation. Transl Rese 2018;191:29–44.

33 LiangW, QiY, YiH et al. The roles of adipose tissue macrophages in human disease. Front Immunol 2022;13:908749.

34 LinkousA, Yazlovitskaya E. Cytosolic phospholipase A2 as a mediator of disease pathogenesis. Cell Microbiol 2010;12:1369–1377.

35 LiuR, ChenY, FuW et al. Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against inflammatory arthritis. Ann Rheum Dis 2019;78:1524–1535.

36 LumengCN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest 2011;121:2111–2117.

37 LumengCN, BodzinJL, SaltielAR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007a;117:175–184.

38 LumengCN, Deyoung SM, BodzinJL et al. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007b;56:16–23.

39 MedrikovaD, Jilkova ZM, BardovaK et al. Sex differences during the course of diet-induced obesity in mice: adipose tissue expandability and glycemic control. Int J Obes (Lond) 2012;36:262–272.

40 MosetiD, Regassa A, KimWK. Molecular regulation of adipogenesis and potential anti-adipogenic bioactive molecules. Int J Mol Sci 2016;17:124.

41 MurrayPJ, AllenJE, BiswasSK et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014;41:14–20.

42 OnakpoyaI, HuntK, WiderB et al. Pyruvate supplementation for weight loss: a systematic review and meta-analysis of randomized clinical trials. Crit Rev Food Sci Nutr 2014;54:17–23.

43 PalmerBF, CleggDJ. The sexual dimorphism of obesity. Mol Cell Endocrinol 2015;402:113–119.

44 ParhoferKG. Interaction between glucose and lipid metabolism: more than diabetic dyslipidemia. Diabetes Metab J 2015;39:353–362.

45 PeñaL, MeanaC, AstudilloAM et al. Critical role for cytosolic group IVA phospholipase A2 in early adipocyte differentiation and obesity. Biochim Biophys Acta 2016;1861:1083–1095.

46 PetersenRK, Jørgensen C, RustanAC et al. Arachidonic acid-dependent inhibition of adipocyte differentiation requires PKA activity and is associated with sustained expression of cyclooxygenases. J Lipid Res 2003;44:2320–2330.

47 PulathanZ, AltunG, HemşinliD et al. Role of ethyl pyruvate in systemic inflammatory response and lung injury in an experimental model of ruptured abdominal aortic aneurysm. Biomed Res Int 2014;2014:857109.

48 ReillySM, Saltiel AR. Adapting to obesity with adipose tissue inflammation. Nat Rev Endocrinol 2017;13:633–643.

49 RosenED, Spiegelman BM. What we talk about when we talk about fat. Cell 2014;156:20–44.

50 RosenED, WalkeyCJ, PuigserverP et al. Transcriptional regulation of adipogenesis. Genes Dev 2000;14:1293–1307.

51 SatoH, Taketomi Y, MikiY et al. Secreted phospholipase PLA2G2D contributes to metabolic health by mobilizing ω3 polyunsaturated fatty acids in WAT. Cell Rep 2020;31:107579.

52 SunY, GeX, LiX et al. High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction. Cell Death Dis 2020;11:914.

53 SurmiB, HastyA. Macrophage infiltration into adipose tissue: initiation, propagation and remodeling. Future Lipidol 2008a;3:545–556.

54 The Lancet, G. & Hepatology. Obesity: another ongoing pandemic. Lancet Gastroenterol Hepatol 2021;6:411.

55 ThyagarajanB, FosterMT. Beiging of white adipose tissue as a therapeutic strategy for weight loss in humans. Horm Mol Biol Clin Investig 2017;31.

56 TianX, YanC, LiuM et al. CREG1 heterozygous mice are susceptible to high fat diet-induced obesity and insulin resistance. PLoS One 2017;12:e0176873.

57 TitosE, RiusB, González-PérizA et al. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J Immunol 2011;187:5408–5418.

58 TsuruH, OSAKAM, HiraokaY et al. HFD-induced hepatic lipid accumulation and inflammation are decreased in Factor D deficient mouse. Sci Rep 2020;10:17593.

59 UozumiN, KumeK, NagaseT et al. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature 1997;390:618–622.

60 WangL, ZhaoRP, SongXY et al. Targeting ERβ in macrophage reduces crown-like structures in adipose tissue by inhibiting osteopontin and HIF-1α. Sci Rep 2019;9:15762.

61 WangY, TangB, LongL et al. Improvement of obesity-associated disorders by a small-molecule drug targeting mitochondria of adipose tissue macrophages. Nat Commun 2021;12:102.

62 WeisbergSP, MccannD, DesaiM et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest, 2003;112, 1796–1808.

63 WellenKE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003;112:1785–1788.

64 WhiteheadA, KrauseFN, MoranA et al. Brown and beige adipose tissue regulate systemic metabolism through a metabolite interorgan signaling axis. Nat Commun 2021;12:1905.

65 WinzellM, AhrenB. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 2004;53:S215–S219.

66 WynnTA, ChawlaA, PollardJW. Macrophage biology in development, homeostasis and disease. Nature 2013;496:445–455.

67 ZhongW, MaM, XieJ et al. Adipose-specific deletion of the cation channel TRPM7 inhibits TAK1 kinase-dependent inflammation and obesity in male mice. Nat Commun 2023;14:491.